Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECS vs ECF in locally advanced breast cancer
NCT01849380Phase 4Unknown
- Sponsor
- Shandong University
- Start
- Jun 2013
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tegafur in breast cancer, sponsored by Shandong University. Status: unknown.
02
Drugs
tegafur
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01849380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01849380.